You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TERAZOL 7 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Terazol 7 patents expire, and when can generic versions of Terazol 7 launch?

Terazol 7 is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in TERAZOL 7 is terconazole. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the terconazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Terazol 7

A generic version of TERAZOL 7 was approved as terconazole by TARO on April 6th, 2004.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TERAZOL 7?
  • What are the global sales for TERAZOL 7?
  • What is Average Wholesale Price for TERAZOL 7?
Summary for TERAZOL 7
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 59
Patent Applications: 5,358
DailyMed Link:TERAZOL 7 at DailyMed
Drug patent expirations by year for TERAZOL 7

US Patents and Regulatory Information for TERAZOL 7

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms TERAZOL 7 terconazole CREAM;VAGINAL 019579-001 Dec 31, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TERAZOL 7

See the table below for patents covering TERAZOL 7 around the world.

Country Patent Number Title Estimated Expiration
Spain 465981 ⤷  Sign Up
Kenya 3270 1-(1,3-DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES AND 1H-1,2,4-TRIAZOLES ⤷  Sign Up
Malaysia 8400209 1-(1,3-DIOXLAN-2-YLMETHYL)-H-IMIDAZOLES AND 1H-1,2.4-TRIAZOLES ⤷  Sign Up
Hungary 177646 PROCESS FOR PRODUCING NEW 1-BRACKET-1,3-DIOXOLANE-2-YL-METHYL-BRACKET CLOSED-1H-IMIDASOLE DERIVATIVES ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.